* The 5-Year EBITDA Growth Rate is the 5-year average EBITDA per share growth rate. While the denominator is a percentage, we use the whole number as opposed to the decimal form for the calculation. For example, 5% would be shown as 5 as opposed to 0.05. If it's smaller than or equal to 0, then the PEG Ratio is not calculated.
The historical rank and industry rank for Modern Chinese Medicine Group Co's PEG Ratio or its related term are showing as below:
HKSE:01643'
s PEG Ratio Range Over the Past 10 Years
Min: 0.08 Med: 0.12 Max: 0.56
Current: 0.53
During the past 7 years, Modern Chinese Medicine Group Co's highest PEG Ratio was 0.56. The lowest was 0.08. And the median was 0.12.
HKSE:01643's PEG Ratio is ranked better than 88.47% of 373
companies
in the Drug Manufacturers industry
Industry Median: 1.63
vs HKSE:01643: 0.53
Peter Lynch thinks a company with a P/E ratio equal to its growth rate is fairly valued.
Modern Chinese Medicine Group Co PEG Ratio Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of Modern Chinese Medicine Group Co's PEG Ratio
For the Drug Manufacturers - General subindustry, Modern Chinese Medicine Group Co's PEG Ratio, along with its competitors' market caps and PEG Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Modern Chinese Medicine Group Co's PEG Ratio Distribution in the Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Modern Chinese Medicine Group Co's PEG Ratio distribution charts can be found below:
* The bar in red indicates where Modern Chinese Medicine Group Co's PEG Ratio falls into.
Modern Chinese Medicine Group Co PEG Ratio Calculation
PEG Ratio is defined as the PE Ratio without NRI divided by the growth ratio.
The ratio we use is the 5-Year EBITDA growth rate.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
* Note: The 5-Year EBITDA Growth Rate is the 5-year average EBITDA per share growth rate. While the denominator is a percentage, we use the whole number as opposed to the decimal form for the calculation. For example, 5% would be shown as 5 as opposed to 0.05. If it's smaller than or equal to 0, then the PEG Ratio is not calculated.
Modern Chinese Medicine Group Co (HKSE:01643) PEG Ratio Explanation
To compare stocks with different growth rates, Peter Lynch invented a ratio called PEG Ratio. PEG Ratio is defined as the P/E ratio divided by the growth ratio. He thinks a company with a P/E ratio equal to its growth rate is fairly valued. Still he said he would rather buy a company growing 20% a year with a P/E of 20, instead of a company growing 10% a year with a P/E of 10.
Modern Chinese Medicine Group Co PEG Ratio Related Terms
Thank you for viewing the detailed overview of Modern Chinese Medicine Group Co's PEG Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.
Modern Chinese Medicine Group Co (HKSE:01643) Business Description
Modern Chinese Medicine Group Co Ltd is engaged in the production of proprietary Chinese medicine. It offers both OTC and prescribed medicines intended for use by the Middle-aged and the Elderly in the PRC. Its products include Vigour and Vitality Supplement Pill, Circulation Enhancement Pill, Cardiotonic Enhancement Capsule, Kidney Invigoration Pill, Heart Wellness Capsule, Menstrual Discomfort Relief Pill, Liver Detox Tablet, and Additional Ingredient Huoxiang ZhengQi Pill and Fever-removing and Detoxification Pill. The Group has one operating segment of its business as a whole as the production of PCM. Geographically, the majority is from PRC.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
HKSE:01643 has been successfully added to your 